Article Text

Treg and lupus
  1. M Bonelli,
  2. J S Smolen,
  3. C Scheinecker
  1. Division of Rheumatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria
  1. Correspondence to Dr C Scheinecker, University of Vienna, Waehringer Guertel 18-20 Vienna A-1090, Austria; clemens.scheinecker{at}


Autoimmune diseases such as systemic lupus erythemathodes (SLE) display quantitative and/or qualitative deficiencies of CD4+CD25+ regulatory T cells (Treg). This might contribute to the immune dysregulation and break-down of peripheral tolerance mechanisms. In addition novel subsets of Treg might arise under specific autoimmune conditions as an effort to counteract autoimmunity. Advances in our understanding of how to characterise and manipulate Treg in patients with autoimmune diseases are required in order to develop new therapeutic strategies.

Statistics from


  • Competing interests None.

  • Provenance and Peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.